Copyright
©The Author(s) 2015.
World J Transplant. Mar 24, 2015; 5(1): 19-25
Published online Mar 24, 2015. doi: 10.5500/wjt.v5.i1.19
Published online Mar 24, 2015. doi: 10.5500/wjt.v5.i1.19
Figure 1 Improvement of serum creatinine (mg/dL) after conversion to mammalian target of rapamycin inhibitors.
Cr: Serum creatinine mg/dL; Baseline: Serum creatinine just before conversion.
Figure 2 Improvement of serum creatinine (mg/dL) after conversion to mammalian target of rapamycin inhibitors in different groups.
Baseline: Serum creatinine just before conversion; Cr: Serum creatinine mg/dL; DM: Diabetes mellitus; HT: Hypertension.
Figure 3 Improvement of serum creatinine (mg/dL) after conversion to mammalian target of rapamycin inhibitors in different groups.
Baseline: Serum creatinine just before conversion; DM: Diabetes mellitus; HT: Hypertension; Prot: Proteinuria.
- Citation: Álamo JM, Olivares C, Barrera L, Marín LM, Suarez G, Bernal C, Serrano J, Muntané J, Padillo FJ, Gómez MA. Conversion from calcineurin inhibitors to mTOR inhibitors stabilizes diabetic and hypertensive nephropathy after liver transplant. World J Transplant 2015; 5(1): 19-25
- URL: https://www.wjgnet.com/2220-3230/full/v5/i1/19.htm
- DOI: https://dx.doi.org/10.5500/wjt.v5.i1.19